FDA warns against smart watch glucose measurement

The Food and Drug Administration (FDA) has cautioned against the use of smart watches and smart rings for measuring blood glucose levels, citing potential inaccuracies that could impact diabetes management. This warning comes as Apple reportedly explores technologies to enable blood sugar monitoring without the need for finger pricks.

In a statement issued on Wednesday, the FDA highlighted that it has not approved any “non-invasive” smart watches or rings for blood glucose measurement without skin pricks. The agency emphasized that relying on such technologies could lead to errors in diabetes management, potentially resulting in incorrect insulin doses or the use of medications that rapidly lower blood sugar levels, leading to serious health risks such as coma or death.

It is important to note that the FDA’s warning pertains to devices sold online that claim to measure blood glucose levels without the need for traditional skin pricks. These devices are distinct from smart watches that display data from separate glucose monitoring tools.

Apple is reportedly working on non-invasive blood glucose monitoring technology for its smart watches. However, it remains unclear whether Apple intends to seek FDA approval for this technology. Bloomberg reports suggest that an early version of Apple’s technology may focus on alerting users to trends in their glucose levels rather than providing precise readings.

The prevalence of diabetes in the United States is significant, with approximately 37.3 million Americans affected, including those with types 1 and 2 diabetes, as well as gestational diabetes among pregnant women. Alarmingly, nearly one in five individuals with diabetes is unaware of their condition. Additionally, an estimated 96 million Americans are believed to have prediabetes, with the majority unaware of their prediabetic status.

The costs associated with diabetes in the United States are substantial, totaling around $413 billion annually. This figure includes both medical expenses and lost productivity due to diabetes-related issues. The CDC attributes the increasing prevalence of diabetes to factors such as an aging population and rising obesity rates, which have contributed to a doubling in the number of diagnosed cases among U.S. adults over the past two decades.

In conclusion, while Apple and other companies explore innovative technologies for blood glucose monitoring, the FDA’s warning underscores the importance of using approved and reliable methods for managing diabetes. Ensuring the accuracy and safety of blood glucose measurements is crucial for effective diabetes management and overall health.